BTS
AZN icon

BB&T Securities’s AstraZeneca AZN Stock Holding History

BB&T Securities’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$2.43M Buy
27,224
+341
+1% +$29.6K 0.02% 530
2019
Q2 		$2.22M Buy
26,883
+755
+3% +$59.2K 0.02% 563
2019
Q1 		$2.11M Sell
26,128
-61,331
-70% -$4.83M 0.02% 562
2018
Q4 		$6.64M Sell
87,459
-26,461
-23% -$2.07M 0.07% 314
2018
Q3 		$9.01M Sell
113,920
-24,189
-18% -$1.83M 0.09% 295
2018
Q2 		$9.7M Sell
138,109
-9,701
-7% -$698K 0.1% 263
2018
Q1 		$10.3M Sell
147,810
-1,688
-1% -$117K 0.12% 237
2017
Q4 		$10.4M Sell
149,498
-287
-0.2% -$19.4K 0.13% 214
2017
Q3 		$10.1M Buy
149,785
+19,214
+15% +$1.21M 0.14% 210
2017
Q2 		$8.9M Buy
130,571
+7,121
+6% +$465K 0.13% 220
2017
Q1 		$7.69M Buy
123,450
+11,364
+10% +$662K 0.1% 228
2016
Q4 		$7.37M Hold
112,086
– – 0.11% 220
2016
Q3 		$7.37M Buy
112,086
+36,657
+49% +$2.4M 0.11% 214
2016
Q2 		$4.55M Buy
75,429
+15,821
+27% +$919K 0.07% 283
2016
Q1 		$3.36M Buy
59,608
+22,778
+62% +$1.37M 0.06% 304
2015
Q4 		$2.5M Sell
36,830
-1,704
-4% -$112K 0.05% 299
2015
Q3 		$2.45M Buy
38,534
+17,813
+86% +$1.17M 0.05% 297
2015
Q2 		$1.32M Buy
20,721
+8,646
+72% +$592K 0.03% 460
2015
Q1 		$826K Sell
12,075
-2,306
-16% -$160K 0.02% 577
2014
Q4 		$1.01M Sell
14,381
-271
-2% -$19.4K 0.02% 499
2014
Q3 		$1.05M Sell
14,652
-4,085
-22% -$299K 0.02% 458
2014
Q2 		$1.39M Sell
18,737
-102,744
-85% -$7.43M 0.03% 364
2014
Q1 		$7.88M Sell
121,481
-4,193
-3% -$271K 0.2% 97
2013
Q4 		$7.46M Buy
125,674
+4,774
+4% +$259K 0.21% 104
2013
Q3 		$6.28M Sell
120,900
-5,872
-5% -$295K 0.19% 104
2013
Q2 		$6M Buy
+126,772
New +$6.46M 0.2% 100

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BB&T Securities's AZN Position: Q3 2019 in Review

BB&T Securities increased its AstraZeneca (AZN) stake by 1.3% in Q3 2019, buying an estimated $29.6K and bringing the position to 27,224 shares worth $2.43M. The position accounts for 0.02% of the portfolio, ranked #530.

BB&T Securities first reported a position in AZN in Q2 2013 and has held it in 26 quarters since. The position peaked at $10.4M in Q4 2017. 555 funds tracked by Wall St. Rank hold AZN as of Q3 2019.

  • BB&T Securities held 27,224 shares of AstraZeneca worth $2.43M as of Q3 2019.
  • BB&T Securities bought 341 AstraZeneca shares in Q3 2019, an estimated $29.6K.
  • AstraZeneca made up 0.02% of BB&T Securities's portfolio in Q3 2019, its #530 holding.
  • BB&T Securities first reported a position in AstraZeneca in Q2 2013 and has held it in 26 quarters since.
  • BB&T Securities's AstraZeneca position peaked at $10.4M in Q4 2017.
  • 555 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.